Etheros Pharmaceuticals
PrivateLast Round
VC Round
Dec 9, 2025
Total Funding Raised
$950,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Etheros Pharmaceuticals is a drug discovery company developing a new class of small molecule drugs which mimic endogenous enzymes to prevent oxidative and inflammatory injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Etheros Pharmaceuticals Comparables
Compare Etheros Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morningside | 77% | |
| Recursion Pharmaceuticals | 65% | |
| Ventyx Biosciences | 58% |
Etheros Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 9, 2025 | ||||
| Debt | Jun 10, 2025 | ||||
| Seed | Mar 1, 2023 |
Etheros Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Backed VC | Seed, VC Round |
| VitaDAO | Seed |
| Immortal Dragons | VC Round |
| Healthspan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2025
Led by Immortal Dragons with participation from Backed VC.
- Jun 10, 2025
$600K debt round raised.
Etheros Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Etheros Pharmaceuticals's valuation, stock price, and market status.
Is Etheros Pharmaceuticals a public or private company?
Etheros Pharmaceuticals is a private company.
What is the current stock price of Etheros Pharmaceuticals?
Etheros Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Etheros Pharmaceuticals worth (valuation)?
Valuation information for Etheros Pharmaceuticals is not publicly available.
Can I buy Etheros Pharmaceuticals stock?
Etheros Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Etheros Pharmaceuticals's last funding round?
Funding round information for Etheros Pharmaceuticals is not publicly available.
Who are the main investors in Etheros Pharmaceuticals?
Investor information for Etheros Pharmaceuticals is not publicly disclosed.
Will Etheros Pharmaceuticals IPO soon?
No public IPO plans have been announced for Etheros Pharmaceuticals.
How can I track Etheros Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Etheros Pharmaceuticals's secondary market activity and sign up for updates.